News
9h
Zacks.com on MSNNovavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
BofA notes that Novavax (NVAX) shares are up 21% after announcing the company has received communication from the FDA for a post marketing ...
1d
Zacks.com on MSNNovavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowNovavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from ...
An ivonescimab-chemotherapy combination succeeded in a study in China. Elsewhere, the FDA asked Novavax for more COVID ...
Brad Smith outlines the top stories on Wall Street as part of Yahoo Finance's Market Minute. Vertiv Holdings (VRT) stock is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results